echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Chemicals Industry > International Chemical > Issue 8, 2016 - Indolama completes the acquisition of Cepsa PTA assets

    Issue 8, 2016 - Indolama completes the acquisition of Cepsa PTA assets

    • Last Update: 2022-11-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    It is reported that Thailand's Indorama (Indorama) recently said that the company has completed the previously announced acquisition
    of polyethylene terephthalate (PET), purified terephthalic acid (PTA) and semiphthalic acid (PIA) assets of Cepsa's chemical subsidiary in Spain.
    These units are located in San Roque
    , Spain.
    Indolama said the company had completed the formalities for the transaction and had officially taken over the assets
    on April 7.

    The acquired assets in San Roque include PIA with an annual capacity of 220,000 tons, PTA of 325,000 tons and PET of 175,000 tons, as well as 230 employees
    .


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.